|
20 Nov 2007 |
Cardiome Initiates Phase 1 Study for GED-aPC
|
|
19 Nov 2007 |
Pacgen Initiates a Phase IIb Clinical Trial For PAC-113
|
|
19 Nov 2007 |
TransMolecular Reports Positive Phase 2 Data from Study of 131 Iodine Radiolabeled TM-601 in Recurrent Glioma
|
|
16 Nov 2007 |
FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
|
|
15 Nov 2007 |
PEGINTRON(TM) and REBETOL(R) Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non-Pegylated Interferon Therapy
|
|
15 Nov 2007 |
Oramed Pharmaceuticals Successfully Completes Animal Studies for Phase 1B Clinical Trials Of Its Oral Insulin Capsule
|
|
15 Nov 2007 |
FDA approves Mircera: first renal anemia treatment in the US with monthly maintenance dosing
|
|
15 Nov 2007 |
FDA approves Mircera: first renal anemia treatment in the US with monthly maintenance dosing
|
|
15 Nov 2007 |
Pramlintide and Leptin Combination Treatment Demonstrates 12.7 Percent Weight Loss in 24-Week Clinical Obesity Study
|
|
13 Nov 2007 |
Insmed Advances Follow on Biologics Initiative
|
|
13 Nov 2007 |
Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
|
|
13 Nov 2007 |
Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
|
|
12 Nov 2007 |
Akela Pharma Announces Final Positive Results From Its Growth Hormone Releasing Hormone (GHRH) Phase II Trial
|
|
12 Nov 2007 |
DIREVO and Pfizer collaborate on therapeutic proteases
|
|
09 Nov 2007 |
Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
|
|
09 Nov 2007 |
PTH 1-34, Phase 2a Clinical Trials Initiated
|
|
07 Nov 2007 |
Biovitrum Announces Future Roadmap - Increased Focus on Specialist Care Diseases
|
|
07 Nov 2007 |
BioGeneriX and Neose Technologies Announce Positive Data from Two Phase I Studies of GlycoPEG-GCSF
|
|
07 Nov 2007 |
Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
|
|
05 Nov 2007 |
Bayer Temporarily Suspends Global Trasylol(R) Marketing
|
|
05 Nov 2007 |
MannKind Announces Positive Results from a Phase 1a Study of a GLP-1 Formulation
|
|
05 Nov 2007 |
Transition Therapeutics Provides Update on Diabetes Program
|
|
05 Nov 2007 |
Affymax(R) Announces Hematide(TM) Successfully Restores Hemoglobin in Patients with Pure Red Cell Aplasia (PRCA)
|
|
05 Nov 2007 |
Human genome sciences presents results of Phase 2 trial of albuferon(R) in chronic hepatitis c patients who failed to respond to previous therapy
|
|
05 Nov 2007 |
Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting
|
